Biblio
Found 155 results
Author Keyword Title Type [ Year] Filters: First Letter Of Keyword is H [Clear All Filters]
“Genomics in neurological disorders.”, Genomics Proteomics Bioinformatics, vol. 12, no. 4, pp. 156-63, 2014.
, “Next generation sequencing techniques in neurological diseases: redefining clinical and molecular associations.”, Hum Mol Genet, vol. 23, no. R1, pp. R47-53, 2014.
, “Next generation sequencing techniques in neurological diseases: redefining clinical and molecular associations.”, Hum Mol Genet, vol. 23, no. R1, pp. R47-53, 2014.
, “Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease.”, Nature, vol. 505, no. 7484, pp. 550-554, 2014.
, “Using machine learning and high-throughput RNA sequencing to classify the precursors of small non-coding RNAs.”, Methods, vol. 67, no. 1, pp. 28-35, 2014.
, “Using machine learning and high-throughput RNA sequencing to classify the precursors of small non-coding RNAs.”, Methods, vol. 67, no. 1, pp. 28-35, 2014.
, “Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals.”, JAMA Neurol, vol. 72, no. 11, pp. 1313-23, 2015.
, “Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals.”, JAMA Neurol, vol. 72, no. 11, pp. 1313-23, 2015.
, “Developmentally stable whole-brain volume reductions and developmentally sensitive caudate and putamen volume alterations in those with attention-deficit/hyperactivity disorder and their unaffected siblings.”, JAMA Psychiatry, vol. 72, no. 5, pp. 490-9, 2015.
, “Developmentally stable whole-brain volume reductions and developmentally sensitive caudate and putamen volume alterations in those with attention-deficit/hyperactivity disorder and their unaffected siblings.”, JAMA Psychiatry, vol. 72, no. 5, pp. 490-9, 2015.
, “Genetic diagnosis and prognosis of Alzheimer's disease: challenges and opportunities.”, Expert Rev Mol Diagn, vol. 15, no. 3, pp. 339-48, 2015.
, “Genetic overlap between Alzheimer's disease and Parkinson's disease at the MAPT locus.”, Mol Psychiatry, vol. 20, no. 12, pp. 1588-95, 2015.
, “Genetically predicted body mass index and Alzheimer's disease-related phenotypes in three large samples: Mendelian randomization analyses.”, Alzheimers Dement, vol. 11, no. 12, pp. 1439-1451, 2015.
, “Genetics of CD33 in Alzheimer's disease and acute myeloid leukemia.”, Hum Mol Genet, vol. 24, no. 12, pp. 3557-70, 2015.
, “HIPPIE: a high-throughput identification pipeline for promoter interacting enhancer elements.”, Bioinformatics, vol. 31, no. 8, pp. 1290-2, 2015.
, “A multiancestral genome-wide exome array study of Alzheimer disease, frontotemporal dementia, and progressive supranuclear palsy.”, JAMA Neurol, vol. 72, no. 4, pp. 414-22, 2015.
, “Next-generation gene discovery for variants of large impact on lipid traits.”, Curr Opin Lipidol, vol. 26, no. 2, pp. 114-9, 2015.
, “Next-generation gene discovery for variants of large impact on lipid traits.”, Curr Opin Lipidol, vol. 26, no. 2, pp. 114-9, 2015.
, “Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease.”, Circulation, vol. 131, no. 23, pp. 2061-2069, 2015.
, “Rarity of the Alzheimer disease-protective APP A673T variant in the United States.”, JAMA Neurol, vol. 72, no. 2, pp. 209-16, 2015.
, “Transcriptomic Changes Due to Cytoplasmic TDP-43 Expression Reveal Dysregulation of Histone Transcripts and Nuclear Chromatin.”, PLoS One, vol. 10, no. 10, p. e0141836, 2015.
, “Transcriptomic Changes Due to Cytoplasmic TDP-43 Expression Reveal Dysregulation of Histone Transcripts and Nuclear Chromatin.”, PLoS One, vol. 10, no. 10, p. e0141836, 2015.
, “Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci.”, PLoS One, vol. 11, no. 2, p. e0148717, 2016.
, “DASHR: database of small human noncoding RNAs.”, Nucleic Acids Res, vol. 44, no. D1, pp. D216-22, 2016.
, “Defining the Genetic Architecture of Alzheimer's Disease: Where Next.”, Neurodegener Dis, vol. 16, no. 1-2, pp. 6-11, 2016.
,